Practice-oriented notes from Boyle (2024): accurate attentional assessment supports ADHD diagnosis and treatment planning; CTMT-2 studied as a supplemental tool alongside WISC-V, CAt-C, and TEA-Ch2.
Practice-facing takeaways from Mizock et al. (2019): self-determination, resource evaluation, and moving beyond risk-only conversations about motherhood and SMI.
Boyle (2024): CTMT-2 performance correlated with WISC-V Processing Speed and TEA-Ch2 selective/everyday attention in school-aged children and adolescents (N = 30, ages 8–15)—supporting CTMT-2 as a supplemental ADHD-related attentional assessment tool.